"instanceType","description","uuid:ID","label","identifier","id","name","text"
"ELIGIBILITY_CRITERIA","The study age criterion","3a0f5597-1434-4ddf-98aa-a6075f20eb4a","","1","EligibilityCriteria_1","Age Criteria","Subjects shall be between [min_age] and [max_age]"
"ELIGIBILITY_CRITERIA","The study population criterion","ff8ce364-edfe-44ca-8be9-33719ed17c89","","2","EligibilityCriteria_2","Pop Criteria","[StudyPopulation] as defined by the NINCDS and the ADRDA guidelines (Attachment LZZT.7)"
"ELIGIBILITY_CRITERIA","The study diagnosis criterion","d9b0ad24-6102-4453-8617-c123c91be6ad","","3","EligibilityCriteria_3","Diag Criteria","[Activity1] score of 10 to 23"
"ELIGIBILITY_CRITERIA","The previous xanomeline TTS criterion","9da4b2bb-e39f-45b9-a9c5-08acebd4e17d","","9","EligibilityCriteria_4","Previous Criteria","Persons who have previously completed or withdrawn from this study or any other study investigating xanomeline TTS or the oral formulation of xanomeline."
